Viatris (VTRS) financials

Pharmaceuticals · NASDAQ · Health Care

$19.04 -0.86% Close Oct 30, 2026 Live

Viatris revenue and earnings by year

Viatris's revenue was $14.3 billion in the fiscal year to December 31, 2025, down 3.0% from the year before. Net income was -$3.51 billion, -24.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 2.9% a year on average.

RevenueNet income
$0$10.0B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue14.314.715.416.317.911.911.511.411.911.1
Revenue growth-3.0%-4.5%-5.1%-9.1%49.7%3.9%0.6%-4.0%7.5%—
Gross profit5.05.66.46.55.63.83.94.04.84.7
Gross margin35.1%38.2%41.7%40.0%31.2%31.8%33.9%35.0%40.2%42.4%
Operating income-2.70.00.81.6-0.0-0.20.70.91.40.7
Operating margin-18.6%0.1%5.0%9.9%-0.2%-1.8%6.2%7.9%12.1%6.3%
Net income-3.5-0.60.12.1-1.3-0.70.00.40.70.5
Net margin-24.6%-4.3%0.4%12.8%-7.1%-5.6%0.1%3.1%5.8%4.3%
Diluted EPS-$3.00-$0.53$0.05$1.71-$1.05-$1.11$0.03$0.68$1.29$0.93
Free cash flow2.02.02.52.62.61.01.62.11.81.7

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open VTRS in Markets.

How Viatris makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Developed Markets$2.20B58.6%
Greater China$714M19.0%
Emerging Markets$544M14.5%
Japan Australia & New Zealand$296M7.9%

See also: VTRS returns

No forecast, no recommendation. This page describes Viatris from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.